PMV Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMVP and other ETFs, options, and stocks.About PMVP
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J.
CEODavid H. Mack
CEODavid H. Mack
Employees47
Employees47
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2013
Founded2013
Employees47
Employees47
PMVP Key Statistics
Market cap59.06M
Market cap59.06M
Price-Earnings ratio-0.75
Price-Earnings ratio-0.75
Dividend yield—
Dividend yield—
Average volume295.46K
Average volume295.46K
High today$1.21
High today$1.21
Low today$1.11
Low today$1.11
Open price$1.18
Open price$1.18
Volume412.16K
Volume412.16K
52 Week high$1.84
52 Week high$1.84
52 Week low$0.81
52 Week low$0.81
Stock Snapshot
With a market cap of 59.06M, PMV Pharmaceuticals(PMVP) trades at $1.16. The stock has a price-to-earnings ratio of -0.75.
On 2025-12-17, PMV Pharmaceuticals(PMVP) stock moved within a range of $1.11 to $1.21. With shares now at $1.16, the stock is trading +4.5% above its intraday low and -3.8% below the session's peak.
Trading volume for PMV Pharmaceuticals(PMVP) stock has reached 412.16K, versus its average volume of 295.46K.
The stock's 52-week range extends from a low of $0.81 to a high of $1.84.
The stock's 52-week range extends from a low of $0.81 to a high of $1.84.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own PMVP. This list is generated using Robinhood data, and it’s not a recommendation.